Chugai Pharmaceutical Co., Ltd.
4519
Ранг среди акций
#353
Chugai Pharmaceutical Co., Ltd. is a prominent global pharmaceutical company,... Chugai Pharmaceutical Co., Ltd. is a prominent global pharmaceutical company, operating subsidiaries involved in the full lifecycle of drug development, from research and manufacturing to sales, import, and export, serving both Japanese and international markets. Its commercialized product portfolio spans several key therapeutic areas. These include a robust oncology offering with leading treatments like Avastin, Tecentriq, Perjeta, Alecensa, Herceptin, Kadcyla, Rituxan, Gazyva, and Xeloda. Additionally, it provides medications for bone health (e.g., Actemra, Edirol, Bonviva), renal conditions (such as Mircera and Oxarol), and neurological or other diverse ailments (including Hemlibra, CellCept, and Enspryng). Beyond its existing offerings, the company maintains an active research and development pipeline. This pipeline features multiple promising candidates targeting oncology, orthopedic and joint disorders, autoimmune diseases, kidney-related conditions, and various neurological or other health issues. Strategic partnerships are central to Chugai's operations, most notably a significant alliance with the Roche Group. The company also fosters collaborative research initiatives with academic institutions. Established in 1925, Chugai's headquarters are located in Tokyo, Japan, and it operates as a key subsidiary of Roche Holding Ltd.
Цена акции
$41.34
Рыночная капитализация
$68.04B
Изменение (1 день)
0.05%
Изменение (1 год)
-12.50%
Страна
JP
Торговля Chugai Pharmaceutical Co., Ltd. (4519)
Категория
Healthcare
Коэффициент P/S для Chugai Pharmaceutical Co., Ltd. (4519)
Коэффициент P/S на 2026 TTM: 0
Согласно последним финансовым отчетам и цене акций Chugai Pharmaceutical Co., Ltd., текущий коэффициент P/S (TTM) составляет 0. В конце 2026 он составлял 0.
История P/S для Chugai Pharmaceutical Co., Ltd. с 2026 по 2026
Коэффициент P/S в конце каждого года
| Год | P/S | Изменить |
|---|---|---|
| Недостаточно данных для указанных дат. | ||
Коэффициент P/S для аналогичных компаний или конкурентов
| Компания | P/S | Разница P/S | Страна |
|---|---|---|---|
| 14.32 | - |
US
|
|
| 6.16 | - |
US
|
|
| 7.78 | - |
US
|
|
| 5.48 | - |
US
|
|
| 4.66 | - |
CH
|
